Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Robin, Wijsman"'
Autor:
Arno C. Hessels, Sabine Visser, Stefan Both, Erik W. Korevaar, Johannes A. Langendijk, Robin Wijsman
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 31, Iss , Pp 100616- (2024)
In non-small-cell lung cancer (NSCLC), improving local control through radiotherapy dose escalation might improve survival. However, a photon-based RCT showed increased organ at risk dose exposure and worse overall survival in the dose escalation arm
Externí odkaz:
https://doaj.org/article/41b3fef774014591bffa21599848c34d
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 29, Iss , Pp 100533- (2024)
Background and purpose: Normal tissue complication probability (NTCP) models are developed from large retrospective datasets where automatic contouring is often used to contour the organs at risk. This study proposes a methodology to estimate how dis
Externí odkaz:
https://doaj.org/article/a1beba7595a84120abcf0f4523ace835
Autor:
Francesco Cortiula, Dirk De Ruysscher, Michelle Steens, Robin Wijsman, Anthonie van der Wekken, Martina Alberti, Lizza E.L. Hendriks
Publikováno v:
European Journal of Cancer, 184, 172-178. ELSEVIER SCI LTD
Adjuvant durvalumab is the standard of care for patients with stage III unresectable non-small cell lung cancer (NSCLC), without progression after concurrent chemo-radiation (CCRT). Patients with stage III NSCLC harbouring epidermal growth factor rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9b05118cbb295709652e5237468ab98
https://doi.org/10.1016/j.ejca.2023.02.013
https://doi.org/10.1016/j.ejca.2023.02.013
Autor:
Edith Dieleman, Lisa van der Woude, Rob van Os, Liselotte van Bockel, Ida Coremans, Corine van Es, Katrien De Jaeger, Hans Peter Knol, Willemijn Kolff, Frederike Koppe, Jacqueline Pomp, Bart Reymen, Dominic Schinagl, Femke Spoelstra, Caroline Tissing-Tan, Noelle van der Voort van Zyp, Antoinet van der Wel, Robin Wijsman, Michel Dielwart, Erwin Wiegman, Ronald Damhuis, Jose Belderbos
Publikováno v:
Clinical Lung Cancer, 24, 2, pp. 130-136
Clinical Lung Cancer, 24, 130-136
Clinical lung cancer, 24(2), 130-136. CIG MEDIA GROUP, LP
Clinical Lung Cancer, 24(2), 130-136. CIG Media Group, L.P.
Clinical lung cancer. Elsevier
Clinical Lung Cancer, 24, 130-136
Clinical lung cancer, 24(2), 130-136. CIG MEDIA GROUP, LP
Clinical Lung Cancer, 24(2), 130-136. CIG Media Group, L.P.
Clinical lung cancer. Elsevier
In this national lung cancer audit of inoperable NSCLC patients, acute toxicity and 3-month mortality of curative chemoradiation was analyzed. Another important question was whether concurrent chemoradiation for elderly stage III NSCLC patients is sa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c88ebab86a06e21a020793c3375fe9a2
https://doi.org/10.1016/j.cllc.2022.11.008
https://doi.org/10.1016/j.cllc.2022.11.008
Autor:
Tineke W.H. Meijer, Robin Wijsman, Edwin A. Usmanij, Olga C.J. Schuurbiers, Peter van Kollenburg, Liza Bouwmans, Johan Bussink, Lioe-Fee de Geus-Oei
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 7, Iss , Pp 16-22 (2018)
Background and purpose: Prognosis of locally advanced non-small cell lung cancer remains poor despite chemoradiation. This planning study evaluated a stereotactic boost after concurrent chemoradiotherapy (30 × 2 Gy) to improve local control. The max
Externí odkaz:
https://doaj.org/article/e72f8cb9d2ee44189519443b0c51628c
Autor:
Sabine Visser, Erik W. Korevaar, Christina T. Muijs, Robin Wijsman, Johannes A. Langendijk, Pietro Pisciotta, Gabriel Gutteres Marmitt, Cássia O. Ribeiro, Stefan Both
Publikováno v:
Radiotherapy and Oncology, 182:109575. ELSEVIER IRELAND LTD
Purpose: Despite the anticipated clinical benefits of intensity-modulated proton therapy (IMPT), plan robustness may be compromised due to its sensitivity to patient treatment uncertainties, especially for tumours with large motion. In this study, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::794a2f08a66587fdc4f44ca5ee198b29
https://hdl.handle.net/11370/e230006a-6e89-44a7-ae2b-24d30f260386
https://hdl.handle.net/11370/e230006a-6e89-44a7-ae2b-24d30f260386
Autor:
Andreas Smolders, Adriaan C. Hengeveld, Stefan Both, Robin Wijsman, Johannes A. Langendijk, Damien C. Weber, Anthony J. Lomax, Francesca Albertini, Gabriel Guterres Marmitt
Publikováno v:
Radiotherapy & Oncology, 182
Smolders, A; Hengeveld, A C; Both, S; Wijsman, R; Langendijk, J A; Weber, D C; Lomax, T; Albertini, F; Guterres Marmitt, G (2023). Inter-and intrafractional 4D dose accumulation for evaluating ΔNTCP robustness in lung cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 182(109488), p. 109488. Elsevier Scientific Publ. Ireland 10.1016/j.radonc.2023.109488
Smolders, A; Hengeveld, A C; Both, S; Wijsman, R; Langendijk, J A; Weber, D C; Lomax, T; Albertini, F; Guterres Marmitt, G (2023). Inter-and intrafractional 4D dose accumulation for evaluating ΔNTCP robustness in lung cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 182(109488), p. 109488. Elsevier Scientific Publ. Ireland 10.1016/j.radonc.2023.109488
Background and purpose: Model-based selection of proton therapy patients relies on a predefined reduction in normal tissue complication probability (NTCP) with respect to photon therapy. The decision is necessarily made based on the treatment plan, b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6435f99873256f368760fd2664a6891a
https://hdl.handle.net/20.500.11850/598937
https://hdl.handle.net/20.500.11850/598937
Autor:
Sunyi Zheng, Jiapan Guo, Johannes A. Langendijk, Stefan Both, Raymond N.J. Veldhuis, Matthijs Oudkerk, Peter M.A. van Ooijen, Robin Wijsman, Nanna M. Sijtsema
Publikováno v:
Radiotherapy and Oncology, 180:109483. ELSEVIER IRELAND LTD
Radiotherapy and oncology, 180:109483. Elsevier
Radiotherapy and oncology, 180:109483. Elsevier
BACKGROUND AND PURPOSE: The aim of this study was to develop and evaluate a prediction model for 2-year overall survival (OS) in stage I-IIIA non-small cell lung cancer (NSCLC) patients who received definitive radiotherapy by considering clinical var
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6944ae144d68f157afd0af1a53ea7bf7
https://doi.org/10.1016/j.radonc.2023.109483
https://doi.org/10.1016/j.radonc.2023.109483
Autor:
Robin Wijsman, Jonas Teuwen, Johan Bussink, B. Stam, M. Fernandes, René Monshouwer, Dominic A.X. Schinagl
Publikováno v:
Radiotherapy and Oncology, 165, pp. 52-59
Radiotherapy and Oncology, 165, 52-59. ELSEVIER IRELAND LTD
Radiotherapy and Oncology, 165, 52-59
Radiotherapy and Oncology, 165, 52-59. ELSEVIER IRELAND LTD
Radiotherapy and Oncology, 165, 52-59
Background and purpose: Large radiotherapy (RT) planning imaging datasets with consistently contoured cardiovascular structures are essential for robust cardiac radiotoxicity research in thoracic cancers. This study aims to develop and validate a hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c4dabfa12b9bb4f9a438c5be09efb5a
https://doi.org/10.1016/j.radonc.2021.10.008
https://doi.org/10.1016/j.radonc.2021.10.008
Autor:
Adrian Thummerer, Carmen Seller Oria, Sabine Visser, Paolo Zaffino, Arturs Meijers, Robin Wijsman, Gabriel Guterres Marmitt, Joao Seco, Johannes Langendijk, Antje Knopf, Maria Francesca Spadea, Stefan Both
Publikováno v:
Physica Medica. 104:S33-S34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3abf3cbc7866118809e4625324d3d30c
https://doi.org/10.1016/s1120-1797(22)02192-5
https://doi.org/10.1016/s1120-1797(22)02192-5